```html

Tropical Sprue – A Complete Guide

What is Tropical Sprue?

Tropical sprue is a chronic, post‑infectious disorder of the small intestine that occurs most often in people who have lived in or traveled to tropical and subtropical regions (including parts of Asia, Africa, the Caribbean and Central America). The condition is characterized by inflammation and flattening of the tiny finger‑like projections (villi) that line the intestinal wall, which impairs the absorption of nutrients such as carbohydrates, fats, vitamins and minerals. Because the small intestine becomes “sprouted” (i.e., blunted), patients develop malabsorption, weight loss, and a host of related systemic symptoms.

Although the exact cause remains uncertain, tropical sprue is thought to arise after an acute gastrointestinal infection that triggers an abnormal immune response in susceptible individuals. The disease is not contagious and typically improves with proper treatment, but if left untreated it can lead to serious nutritional deficiencies.

Common Causes

While the precise trigger is unknown, several conditions and risk factors are consistently linked to the development of tropical sprue:

• Acute bacterial or parasitic gastroenteritis – infections with Shigella, Salmonella, Campylobacter or protozoa such as Giardia lamblia.
• Repeated exposure to contaminated water or food – common in regions with poor sanitation.
• Prolonged use of broad‑spectrum antibiotics that disturb normal gut flora.
• Travel to endemic areas for more than 2–3 months, especially in low‑income settings.
• Underlying immune dysregulation – people with HIV, autoimmune disease, or on immunosuppressive therapy appear at higher risk.
• Microscopic intestinal infections that may be difficult to detect on routine stool tests (e.g., Enterotoxigenic E. coli).
• Chronic intestinal inflammation from other causes (e.g., Crohn’s disease) can mimic or predispose to a sprue‑like picture.
• Malnutrition before infection – a weakened mucosal barrier may be more vulnerable.
• Genetic susceptibility – certain HLA types have been associated with higher incidence in some populations.
• Environmental toxins – exposure to certain pesticides or heavy metals has been hypothesized, though evidence is limited.

Associated Symptoms

Because tropical sprue primarily damages the absorptive surface of the small intestine, the clinical picture is dominated by malabsorption‑related complaints. Commonly reported symptoms include:

• Chronic watery or greasy diarrhea (often lasting >4 weeks)
• Unexplained weight loss and failure to thrive
• Abdominal bloating, cramps, and flatulence
• Steatorrhea (fatty, foul‑smelling stools)
• Generalized fatigue and weakness
• Glossitis (smooth, sore tongue) and angular cheilitis
• Peripheral neuropathy (tingling or numbness in hands/feet) due to vitamin B12 deficiency
• Easy bruising or bleeding because of folate deficiency
• Bone pain or fractures from calcium and vitamin D malabsorption
• Palpitations or shortness of breath linked to anemia

When to See a Doctor

Because prolonged malabsorption can quickly lead to serious nutritional deficits, you should seek medical evaluation promptly if you experience any of the following:

• Diarrhea lasting more than 2–3 weeks, especially after travel to a tropical region.
• Unintentional weight loss greater than 5 % of body weight.
• Persistent abdominal pain or bloating that interferes with daily activities.
• Signs of anemia (pallor, fatigue, shortness of breath) or neuropathy (tingling, numbness).
• Visible changes in stool consistency (oily, frothy, foul‑smelling).
• Difficulty concentrating or memory problems—possible vitamin B12 deficiency.

Early assessment can prevent complications such as severe anemia, osteomalacia, or irreversible nerve damage.

Diagnosis

Diagnosing tropical sprue requires a combination of clinical suspicion and targeted investigations:

1. Detailed History & Physical Examination

• Travel history, duration of stay in tropical areas, dietary habits, and exposure to contaminated water.
• Physical signs of malnutrition (e.g., low BMI, edema, glossitis).

2. Laboratory Tests

• Complete blood count (CBC) – often reveals anemia (macrocytic or microcytic).
• Serum electrolytes, albumin, and total protein – low levels suggest malabsorption.
• Vitamin B12, folate, and vitamin D levels – frequently reduced.
• Stool studies – rule out infectious pathogens, ova & parasites, and assess fat content (e.g., fecal fat quantification).
• Serology for celiac disease – to exclude gluten‑sensitive enteropathy.

3. Imaging & Endoscopy

• Upper gastrointestinal endoscopy with duodenal biopsies – the gold standard. Histology typically shows villous atrophy, crypt hyperplasia, and inflammatory infiltrates.
• Capsule endoscopy or enterography – helps visualize more distal small‑bowel disease if initial scope is non‑diagnostic.

4. Exclusion of Other Disorders

Because the presentation overlaps with celiac disease, Crohn’s disease, and other malabsorption syndromes, these conditions must be ruled out through appropriate testing and imaging.

Treatment Options

The therapeutic goal is to eradicate any residual infection, reduce inflammation, and correct nutritional deficiencies.

1. Antibiotic Therapy

• Tetracycline 500 mg four times daily for 3 months is the most widely used regimen (Mayo Clinic).
• Alternative agents include metronidazole or ciprofloxacin** when tetracycline is contraindicated.

2. Nutritional Supplementation

• Folic acid 1 mg daily (often combined with a multivitamin).
• Vitamin B12 intramuscular injections (1,000 µg weekly for 4 weeks, then monthly) or high‑dose oral supplementation.
• Fat‑soluble vitamins (A, D, E, K) and calcium as needed.
• High‑protein, low‑fat diet initially, gradually re‑introducing complex carbohydrates.

3. Anti‑inflammatory and Supportive Medications

• Short courses of corticosteroids (e.g., prednisone 20–40 mg daily for 2–4 weeks) may be employed in severe cases with marked inflammation.
• Probiotics (e.g., Lactobacillus rhamnosus GG) can aid restoration of normal gut flora.

4. Lifestyle Measures

• Strict hydration with oral rehydration solutions or electrolyte‑balanced drinks.
• Avoidance of alcohol and caffeine, which can exacerbate diarrhea.
• Small, frequent meals; incorporate easily digestible foods such as rice, bananas, boiled potatoes, and lean protein.

5. Monitoring & Follow‑up

Repeat laboratory tests and, when indicated, a follow‑up endoscopy after 6–12 months to confirm mucosal healing. Most patients show marked improvement within 4–6 weeks of starting therapy.

Prevention Tips

Because tropical sprue is linked to exposure to contaminated food and water, preventive measures focus on safe travel practices and overall gut health:

• Drink only bottled, boiled, or chemically treated water. Use chlorine tablets or iodine if necessary.
• Eat well‑cooked foods and avoid raw fruits/vegetables unless you can peel them yourself.
• Practice good hand hygiene—wash hands with soap and clean water before meals.
• Consider a short course of prophylactic antibiotics (e.g., azithromycin) only under a physician’s guidance if traveling to high‑risk areas for prolonged periods.
• Maintain a balanced diet rich in fiber, pre‑biotics, and probiotics to support a healthy microbiome.
• When staying in endemic regions, seek prompt medical care for any acute diarrheal illness to reduce the risk of chronic complications.

Emergency Warning Signs

If you notice any of the following, seek immediate medical attention (ER or urgent care):

• Severe dehydration: sunken eyes, rapid heartbeat, dizziness, or inability to keep fluids down.
• Sudden, profuse bleeding from the gastrointestinal tract (black/tarry stools or bright red blood).
• Signs of severe anemia: chest pain, fainting, pronounced shortness of breath with minimal exertion.
• Neurological emergencies: sudden loss of coordination, severe weakness, or unexplained confusion.
• Persistent high fever (>38.5 °C / 101 °F) lasting more than 48 hours despite antipyretics.

---

References:

• Mayo Clinic. “Tropical sprue.” mayoclinic.org. Accessed June 2024.
• World Health Organization. “Foodborne disease epidemiology in low‑ and middle‑income countries.” WHO Fact Sheet, 2023.
• National Institutes of Health (NIH). “Nutritional deficiencies and malabsorption.” NCBI Bookshelf.
• Cleveland Clinic. “Malabsorption syndromes.” clevelandclinic.org.
• Centers for Disease Control and Prevention (CDC). “Travelers’ Health: Diarrhea.” cdc.gov.

```